Dr Karl Dyeser-Oth, a professor at the University of California, Berkeley, was named a 2026 Nobel laureate in Chemistry for inventing a catalyst that can steer the handedness of molecules with unprecedented precision.

Discovery that tipped the balance

The breakthrough, published in 2024, described a metal‑organic framework that directs the formation of one enantiomer over its mirror image in a single step. Traditional methods often require multiple stages and generate waste; Dyeser-Oth’s system achieves the same selectivity while cutting by‑products by more than half, according to the original paper in Nature Chemistry.

His team combined high‑throughput screening with machine‑learning algorithms to fine‑tune ligand environments, a process that took three years of iterative experiments in a Berkeley clean‑room. The catalyst proved effective across a suite of pharmaceutically relevant reactions, from simple alkenes to complex natural‑product scaffolds.

Why it matters for medicine

Chirality – the property that makes a molecule’s left‑handed and right‑handed forms distinct – is a cornerstone of drug safety. Roughly half of all active pharmaceutical ingredients are chiral, and the wrong enantiomer can be ineffective or harmful. By offering a reliable route to a single, desired enantiomer, Dyeser-Oth’s catalyst could streamline the production of life‑saving medicines, potentially lowering costs and accelerating market entry.

Industry analysts note that the technology aligns with a broader push for greener chemistry, reducing solvent use and energy consumption. Several multinational firms have already filed provisional patents to adapt the catalyst to their pipelines, though commercial licences are expected to roll out over the next two years.

Reaction from the scientific community

Colleagues praised the work as a “paradigm shift” in asymmetric synthesis, though they caution that scaling the catalyst from laboratory to industrial reactors will require further engineering. The Royal Swedish Academy of Sciences highlighted the discovery’s “profound impact on how we design and manufacture chiral compounds” in its citation.

At the Nobel ceremony in Stockholm on Tuesday, Dyeser-Oth spoke briefly about the collaborative nature of the research, crediting graduate students and postdoctoral fellows for their hands‑on contributions.

Family pride and public interest

In a video released by ABC News, Dyeser-Oth showed his two children reacting to the news. He described their excitement as “the best validation any scientist can get” and noted that the award has sparked curiosity about chemistry in his household.

Public reaction has been enthusiastic, with social media users sharing the clip and many young viewers asking, “Can I become a scientist too?” Educational organisations are already planning outreach events that feature the Nobel‑winning catalyst as a case study.

The 2026 Nobel Prize in Chemistry also honoured Henri B. Kagan and Kenso Soai for their foundational work on the origin of molecular handedness, underscoring a year focused on chirality’s role in both biology and technology.

As the Nobel Committee announced the remaining awards later this week, Dyeser-Oth’s achievement stands out for its immediate applicability and the human story behind it – a reminder that groundbreaking science often begins in a lab, but its reverberations reach families and factories alike.

Nobel prize ceremony Stockholm, laureates on stage receiving medals